Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
Comparison of Erectile Dysfunction and Optical Coherence Tomography Angiography Findings in Patients With Non Ocular Behçet's Disease
1 other identifier
observational
35
1 country
1
Brief Summary
It was aimed to demonstrate whether erectile dysfunction is affected by BH pathogenesis and whether there is a relationship between erectile dysfunction and BD pathogenesis by assessing both sexual function and retinal micro-vascular blood flow in BH which may involve vessels from all calibrations and nature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2019
CompletedFirst Submitted
Initial submission to the registry
May 2, 2020
CompletedFirst Posted
Study publicly available on registry
May 13, 2020
CompletedMay 13, 2020
May 1, 2020
6 months
May 2, 2020
May 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
International Index of Erectile Function-15
This scale assessing the quality of erectile function within the previous 4 weeks was developed by Rosen et al. in 1997. The Turkish validity study was performed by Turunç et al. \[30\]. The IIEF-15 assesses male sexual function in 5 domains: erectile function (1-30 points), orgasmic function (0-10 points), sexual desire (2-10 points), sexual satisfaction from intercourse (0-15 points) and overall satisfaction (2-10 points). In contrast to other functions, the severity of erectile dysfunction can be rated with an overall score ranging from 6 to 30 points. Erectile function was graded as follows: 0-10 points as severe erectile dysfunction (ED); 11-16 points as moderate ED; 17-21 points as mild-moderate ED; 22-25 points as mild ED; 26-30 points as no erectile dysfunction.
1 week
Optical coherence tomography angiography
It is a functional method that detects the movement contrast in the bloodstream and displays the capillary nets of the retina and choroid and the outer retina without using paint.It is a non-invasive method that provides static volumetric angiography information.From the quantitative measurement results presented by calculating automatically by the software used by the device, the area of the foveal avascular zone (PHASE), the value of the asymmetric index (AI), the superficial and Vascular density (VD) percentages and retinal thickness values in deep capillary plexuses were included in the study.OCTA findings are classified in stages 1-5. OCTA findings worsen as the stage number increases. While stage 1 shows normal superficial capillary plexus; In stage 5, decreased vascular density in the outer retina and significant thinning in the retina are observed.
1 week
Study Arms (1)
Behçet's disease
Male patients who arediagnosed as Behçet's disease according to International Study Group Classification Criteria
Interventions
A complete ophthalmological examination including best-corrected visual acuity using the decimal system (BCVA), measurement of intraocular pressure (IOP) and axial length (AL), slit-lamp examination and dilated fundus examination
Eligibility Criteria
Behçet's disease (BD) is a chronic, multi-systemic vasculitis characterized by remissions and exacerbations, where etiology hasn't been fully elucidated \[1\]. It was first described as oral aphthae, genital ulcerations, and iridocyclitis with hypopyon by Hulusi Behçet in 1937 \[2\]. Although its etiology hasn't been fully understood, it is widely accepted that the disease is caused by excessive inflammatory response triggered by environmental factors in individuals with genetic susceptibility
You may qualify if:
- Definitive diagnosis of Behçet Disease
- No comorbid disease known to be associated with erectile dysfunction, including hypertension and diabetes mellitus
- Not overweight or obese (BMI≤25 kg/m2)
- Non-smokers
- No alcohol and/or substance abuse
- No known psychiatric disorder
You may not qualify if:
- prostatic disorder
- medication that may influence on erectile function (antihistamines, ß-blockers, etc.)
- sacroiliac joint or chronic articular involvement
- family history of glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antalya Tarining and Research Hospital Ethics Commitee
Antalya, Muratpasa, 07070, Turkey (Türkiye)
Related Publications (1)
Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006 Dec;45(12):1461-5. doi: 10.1093/rheumatology/kel329. Epub 2006 Sep 23. No abstract available.
PMID: 16998234RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayse Ayan, Dr.
Antalya Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof, Dr
Study Record Dates
First Submitted
May 2, 2020
First Posted
May 13, 2020
Study Start
June 15, 2019
Primary Completion
December 10, 2019
Study Completion
December 15, 2019
Last Updated
May 13, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
Plan will be shared with Statistical Package for the Social Sciences version 20.